Judge Sweet’s landmark ruling held that isolated gene sequences and their analysis are not patentable under US law. This decision invalidated key BRCA gene patents and marks a significant shift in the legal approach to biotechnology patents in the United States.
Read more about The Gene Returns to its BodyTag: BRCA1
Gene Sequences and Patents: Australian High Court Narrows Scope
The Australian High Court has narrowed the eligibility of gene patents, particularly concerning isolated DNA sequences in the BRCA1 case. This analysis explores the legal reasoning, statutory interpretation, and global impact on biotechnology patent law, following similar US Supreme Court decisions.
Read more about Gene Sequences and Patents: Australian High Court Narrows Scope